← Leaderboards
Al B Benson
Northwestern University
$11,593,650
Attributed
$17,678,242
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,206,015 · 10
FDA$4,472,227 · 1
By mechanism
U10$6,063,420 · 1
UG1$5,460,843 · 1
U01$4,472,227 · 1
P30$1,665,812 · 4
M01$15,940 · 4
Top collaborators
- Daniela E Matei11 shared
- Suzanne Marie Cole2 shared
- Peter J O'Dwyer2 shared
- Xin Victoria Wang2 shared
Most similar at Northwestern University
Same institution · by research overlap
- Mary Sharon Stack$12,179,353
- J. Quentin Clemens$8,740,035
- Marcelo G. Bonini$11,843,749
- Jonathan Widom$10,446,481
- Sharon B. Murphy$8,455,184
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsComprehensive Cancer CenterMalignant NeoplasmsMemberCancer CenterProgramsEnsureUniversitiesResourcesGrantEastern Cooperative Oncology GroupAncillary StudyScienceDisciplinePathologyInstitutionLeadershipTranslational ResearchResearch PersonnelLaboratoriesPublicationsCollaborationsCancer Patient
Grant awards (49)
Northwestern University Lead Academic Participating Site$463,643
UG1 · FY2025 · CA · contact PI
Protocol Review and Monitoring System$121,423
P30 · FY2025 · CA · contact PI
Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making$2,247,715
U01 · FY2024 · FD
Northwestern University Lead Academic Participating Site$949,402
UG1 · FY2024 · CA · contact PI
Protocol Review and Monitoring System$171,974
P30 · FY2024 · CA · contact PI
Northwestern University Lead Academic Participating Site - Revision -5S2$42,000
UG1 · FY2024 · CA · contact PI
Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making$2,224,512
U01 · FY2023 · FD
Northwestern University Lead Academic Participating Site$775,160
UG1 · FY2023 · CA · contact PI
Northwestern University Lead Academic Participating Site, GY4 Supplemental Request$299,998
UG1 · FY2023 · CA · contact PI
Protocol Review and Monitoring System$171,974
P30 · FY2023 · CA · contact PI
Northwestern University Lead Academic Participating Site$515,160
UG1 · FY2022 · CA · contact PI
Protocol Review and Monitoring System$234,357
P30 · FY2022 · CA · contact PI
Northwestern University Lead Academic Participating Site$895,160
UG1 · FY2021 · CA · contact PI
Northwestern University Lead Academic Participating Site Supplement Year 2$315,000
UG1 · FY2021 · CA · contact PI
Protocol Review and Monitoring System$234,357
P30 · FY2021 · CA · contact PI
Northwestern University Lead Academic Participating Site$515,160
UG1 · FY2020 · CA · contact PI
Protocol Review and Monitoring System$234,357
P30 · FY2020 · CA · contact PI
Northwestern University Lead Academic Participating Site$175,000
UG1 · FY2020 · CA · contact PI
Northwestern University Lead Academic Participating Site$515,160
UG1 · FY2019 · CA · contact PI
Protocol Review and Monitoring System$234,357
P30 · FY2019 · CA · contact PI
Protocol Review and Monitoring System$239,009
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$8,620
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$8,488
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$6,896
P30 · FY2018 · CA · contact PI
ECOG Clinical Trials$362,638
U10 · FY2013 · CA · contact PI
ECOG Clinical Trials$415,756
U10 · FY2012 · CA · contact PI
ECOG Clinical Trials$415,756
U10 · FY2011 · CA · contact PI
ECOG Clinical Trials$455,484
U10 · FY2010 · CA · contact PI
Eastern Cooperative Oncology Group Clinical Trials$460,085
U10 · FY2009 · CA · contact PI
Eastern Cooperative Oncology Group Clinical Trials$452,395
U10 · FY2008 · CA · contact PI
Eastern Cooperative Oncology Group Clinical Trials$456,370
U10 · FY2007 · CA · contact PI
NU 98X3: IRINOTECAN (CPT-11) AND GEMCITABINE IN PATIENTS WITH SOLID TUMORS$5,940
M01 · FY2007 · RR · contact PI
Eastern Cooperative Oncology Group Clinical Trials$448,417
U10 · FY2006 · CA · contact PI
Eastern Cooperative Oncology Group Clinical Trials$446,382
U10 · FY2005 · CA
NU 98X3: IRINOTECAN (CPT-11) AND GEMCITABINE IN PATIENTS WITH SOLID TUMORS$4,144
M01 · FY2005 · RR
Eastern Cooperative Oncology Group Clinical Trials$459,386
U10 · FY2004 · CA
NU 98X3: Irinotecan (CPT-11) and Gemcitabine in Patients with Solid Tumors$5,856
M01 · FY2004 · RR
EASTERN COOPERATIVE ONCOLOGY GROUP CLINICAL TRIALS$434,415
U10 · FY2003 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP CLINICAL TRIALS$434,415
U10 · FY2002 · CA
CORE--CLINICAL RESEARCH OFFICE$0
P30 · FY2002 · CA
CORE--CLINICAL RESEARCH OFFICE$0
P30 · FY2002 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP CLINICAL TRIALS$417,036
U10 · FY2001 · CA
PHASE I TRIAL OF IRINOTECAN (CPT 11) AND GEMCITABINE$0
M01 · FY2001 · RR
CORE--CLINICAL TRIAL PROTOCOL REVIEW/MONITORING SYSTEM$0
P30 · FY2001 · CA
CORE--CLINICAL RESEARCH OFFICE$0
P30 · FY2001 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP CLINICAL TRIALS$404,885
U10 · FY2000 · CA
CORE--CLINICAL RESEARCH OFFICE$0
P30 · FY2000 · CA
CORE--CLINICAL RESEARCH OFFICE$0
P30 · FY2000 · CA
PHASE I TRIAL OF IRINOTECAN (CPT 11) AND GEMCITABINE$0
M01 · FY2000 · RR